Skip to main content

Aptinyx Inc.

APTXDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001674365

Aptinyx Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 32 institutions reported holding it in 13F filings for Q1 2023, worth $2.44M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Aptinyx Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of APTX: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders4960+11
Shares34.6M35.8M+1.22M (+3.5%)
Value$92.4M$81.3M−$11.1M (−12.0%)

New holders (12)

Institutions that held Aptinyx Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to APTX in Q1 2022
InstitutionSharesValue% of portfolio
Frazier Life Sciences Management, L.P.1,883,244$4.28M0.36%
Victory Capital Management Inc140,360$319.0K0.00%
Simplex Trading, LLC105,717$239.0K0.01%
Caption Management, LLC69,600$159.0K0.01%
Assenagon Asset Management S.A.68,338$155.0K0.00%
Man Group plc59,866$136.0K0.00%
Cetera Advisor Networks LLC40,600$92.0K0.00%
LGL Partners, LLC19,200$44.0K0.01%
Virtu Financial LLC11,688$27.0K0.00%
Algert Global LLC10,200$23.0K0.00%
Northwestern Mutual Wealth Management Co600$1.00K0.00%
Navigation Wealth Management, Inc.100$00.00%

Sold out (1)

Institutions that held Aptinyx Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of APTX in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Frazier Management LLC1,883,244$5.03M